Ankara City Hospital Bilkent: Observational study completed, 700 enrolled (Difficult Intubation, Holmium Laser Enucleation of the Prostate)
Ankara City Hospital Bilkent: Observational study completed, 700 enrolled (Difficult Intubation, Holmium Laser Enucleation of the Prostate). Its enrollment of 700 is top-decile (92nd percentile of 8,879 records). Dated 28 days ago, it is in the active follow-up window. Score 40/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 700 · 92th percentile of 8,879 ClinicalTrialStartPulse records · 8.8x the median
Free preview: all 14 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | Ankara City Hospital Bilkent |
| Sponsor type | Academic and hospital |
| Study | Difficult Intubation in HoLEP Surgery |
| NCT ID | NCT07688954 |
| Phase | Observational |
| Status | completed |
| Conditions | Difficult Intubation; Holmium Laser Enucleation of the Prostate |
| Target enrollment | 700 |
| Site countries | Turkey (Türkiye) |
| Posted | 2026-07-07 |
| Planned start | 2026-07-05 |
| Event | Completed |
| Event date | 2026-09-15 |
| Last update posted | 2026-10-08 |
| enrollment percentile | 92th of 8,879 (median 80, 8.8x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Ankara City Hospital Bilkent
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock Ankara City Hospital Bilkent + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-08
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Ankara City Hospital Bilkent and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- Ankara City Hospital Bilkent's enrollment: 92nd percentile of 8,879 records
- Timing: Medium: dated in the last 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
40 / 100 Score
- Completed: closeout, analysis and the next study ahead.
- 700 participants planned.
What is the ClinicalTrialStartPulse record for Ankara City Hospital Bilkent?
Ankara City Hospital Bilkent's Observational study (NCT07688954) in Difficult Intubation, first posted 2026-07-07: completed (2026-09-15), in an update posted 2026-10-08.
How does Ankara City Hospital Bilkent compare to other ClinicalTrialStartPulse records?
This is a top-decile record: its enrollment of 700 is 8.8x the median of 80 across 8,879 records. It is 28 days old, still within a typical 45-day follow-up window.
Ankara City Hospital Bilkent vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| Ankara City Hospital Bilkent | NONUS | 700 | 92nd | 2026-10-08 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | NONUS | 366 | 85th | 2026-11-03 |
| Teva Branded Pharmaceutical Products R&D LLC | NONUS | 1,085 | 95th | 2026-11-03 |
| Janssen-Cilag International NV | NONUS | 135 | 68th | 2026-11-03 |
Related records
- Calyxo, Inc.
- Hoffmann-La Roche
- Restor3D
- Kardium Inc.
- Janssen Biotech, Inc.
- Janssen Scientific Affairs, LLC
- Ethicon Endo-Surgery
- Janssen Pharmaceutica N.V., Belgium
- Janssen-Cilag International NV
- Janssen Biotech, Inc.
- Teva Branded Pharmaceutical Products R&D LLC
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
ClinicalTrialStartPulse: Observational ClinicalTrialStartPulse: Outside the US only
How to monitor Ankara City Hospital Bilkent and peer observational records
Get new ClinicalTrialStartPulse records like Ankara City Hospital Bilkent by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.